investment

Silicon Valley VC firm DFJ led the investment in Verge, which is applying machine learning to the development of new drugs for Parkinson's and ALS.

NewStem is developing a technology that uses human haploid embryonic stem cells to predict cancer drug resistance.

It anticipates using the funds to complete the development of its first set of diagnostic products, and for a set of clinical studies to obtain regulatory clearance.

Benchmark led a new investment round in digital lab notebook maker Benchling, which claims 500 percent year-over-year growth in annual recurring revenue.

Luna DNA, which offers a cryptocurrency to reward people for sharing biological and medical data with researchers, has raised $4 million to date.

With the Series B funding, Sytenkabio will consolidate its headquarters in Seoul, validate its technology, and look to expand into international markets.

Large health systems look to the hub-and-spoke model for expanding MDx and other genomic technologies to smaller hospitals, according to HIMSS Analytics research.

Inscripta is creating its own market and customer base while also utilizing the expertise of its customers to refine and improve its products.

The firm said it will use the funding to expand its research capabilities, including the continued development of the MADzyme family of CRISPR enzymes.

The funding will help the Canadian cancer genomics firm expand distribution of its tumor tissue hotspot test, and development of its newer liquid biopsy assay.

Pages

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.